Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Dividends Paid - Common: 2020-2024

Historic Dividends Paid - Common for Maravai Lifesciences Holdings (MRVI) over the last 3 years, with Dec 2024 value amounting to -$78,000.

  • Maravai Lifesciences Holdings' Dividends Paid - Common was N/A to -$78,000 in Q4 2024 from the same period last year, while for Dec 2024 it was $10.1 million, marking a year-over-year change of. This contributed to the annual value of $494,000 for FY2024, which is 94.86% down from last year.
  • According to the latest figures from Q4 2024, Maravai Lifesciences Holdings' Dividends Paid - Common is -$78,000, which was down 113.64% from $572,000 recorded in Q2 2024.
  • In the past 5 years, Maravai Lifesciences Holdings' Dividends Paid - Common ranged from a high of $119.7 million in Q4 2020 and a low of -$78,000 during Q4 2024.
  • For the 3-year period, Maravai Lifesciences Holdings' Dividends Paid - Common averaged around $20.0 million, with its median value being $19.6 million (2022).
  • As far as peak fluctuations go, Maravai Lifesciences Holdings' Dividends Paid - Common skyrocketed by 40,961.48% in 2021, and later slumped by 96.94% in 2023.
  • Over the past 5 years, Maravai Lifesciences Holdings' Dividends Paid - Common (Quarterly) stood at $119.7 million in 2020, then tumbled by 60.61% to $47.2 million in 2021, then slumped by 34.43% to $30.9 million in 2022, then plummeted by 96.94% to $1.3 million in 2023, then crashed by 56.17% to -$78,000 in 2024.
  • Its Dividends Paid - Common was -$78,000 in Q4 2024, compared to $572,000 in Q2 2024 and $1.3 million in Q2 2023.